牛牛AI助理已提取核心訊息
Evelo Biosciences, Inc., a biotechnology company based in Delaware, has filed Post-Effective Amendment No. 1 with the U.S. Securities and Exchange Commission (SEC) on January 26, 2024, to deregister unsold securities under two previous registration statements. The affected securities were initially registered for the company's 2021 Employment Inducement Award Plan and its 2015 Stock Incentive Plan, 2018 Incentive Award Plan, and 2018 Employee Stock Purchase Plan. This move follows the company's board of directors' decision on November 21, 2023, to dissolve the company in accordance with the Delaware General Corporation Law, pending stockholder approval. The deregistration effectively terminates the offerings of securities under the specified registration statements, aligning with the company's plan to dissolve.
Evelo Biosciences, Inc., a biotechnology company based in Delaware, has filed Post-Effective Amendment No. 1 with the U.S. Securities and Exchange Commission (SEC) on January 26, 2024, to deregister unsold securities under two previous registration statements. The affected securities were initially registered for the company's 2021 Employment Inducement Award Plan and its 2015 Stock Incentive Plan, 2018 Incentive Award Plan, and 2018 Employee Stock Purchase Plan. This move follows the company's board of directors' decision on November 21, 2023, to dissolve the company in accordance with the Delaware General Corporation Law, pending stockholder approval. The deregistration effectively terminates the offerings of securities under the specified registration statements, aligning with the company's plan to dissolve.
總部位於特拉華州的生物技術公司Evelo Biosciences, Inc. 已於2024年1月26日向美國證券交易委員會（SEC）提交了生效後第1號修正案，要求根據先前兩份註冊聲明註銷未售出的證券。受影響的證券最初註冊了公司的2021年就業激勵獎勵計劃及其2015年股票激勵計劃、2018年激勵獎勵計劃和2018年員工股票購買計劃。此舉是在公司董事會於2023年11月21日決定根據特拉華州通用公司法解散公司之後採取的，尚待股東批准。取消註冊實際上終止了根據特定註冊聲明發行的證券，這與公司的解散計劃一致。
總部位於特拉華州的生物技術公司Evelo Biosciences, Inc. 已於2024年1月26日向美國證券交易委員會（SEC）提交了生效後第1號修正案，要求根據先前兩份註冊聲明註銷未售出的證券。受影響的證券最初註冊了公司的2021年就業激勵獎勵計劃及其2015年股票激勵計劃、2018年激勵獎勵計劃和2018年員工股票購買計劃。此舉是在公司董事會於2023年11月21日決定根據特拉華州通用公司法解散公司之後採取的，尚待股東批准。取消註冊實際上終止了根據特定註冊聲明發行的證券，這與公司的解散計劃一致。
有用
沒用
該公告為獨立文件：